Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

More documents

Recommendations

Info

32 GLOBAL DRUG FACILITY Annex 1 GDF Key Performance Indicators, 2012 High-level KPI Detailed KPIs Target 1.1. Number of manufacturers by product Ratio of new eligible manufacturers awarded contracts per year 100% 1.2. Number of times emergency orders could not be met with stockpiles over one year 1.3. % of orders where the target lead time was achieved for emergency/routine orders Deviation rate of forecasted versus actual annual volumes for FLDs and SLDs Aggregated deviation rate of contractually agreed stockpile levels per supplier Average lead time from receipt of application to delivery of agreement to country for signing Average lead time from delivery of agreement to country to return of signed agreement to GDF Average lead time between receipt of country-signed agreement and request for price quote Average lead time between request for price quote and availability of price quote Average lead time between financial approval (grant) / receipt of funds (Procurement Services) and order placement Aggregated deviation rate of actual versus agreed lead time between order placement and order dispatch Aggregated deviation rate of actual versus agreed lead time between dispatch and delivery at port +/- 20% +/- 10% < 5 days for Direct Proc Services < 20 days for Grants < 5 days < 3 days < 2 days < 2 days < 10% < 10 % 1.4. GDF price over time by drug % of products for which best market price was achieved 90% 2.2. QA: % of products procured that are SRA or WHO PQ % of TB products recommended by WHO that are available in GDF catalogue 100% 3.1. Number of monitoring missions performed in GDF-supported countries over one year 3.2. Number of TA (technical assistance) reports out of the number of monitoring missions per year 4.1. Composite index from 360º feedback % of missions that did not fully meet the Terms of Reference 0% % of missions conducted by Stop TB Partners > 80% % of TA recommendations implemented > 60% Ratio of TA needs shared with TA providers 100% Average period vacant posts remain unfilled < 120 days Ratio of skill gaps based on Team Leader assessment 5% % of skill gaps being addressed with training 100% 4.2. Staff retention/attrition rate Number of sick days per employees < 5 days/year 4.3. Ratio funding raised/required for GDF activities for staff, grants and operations 4.4. Customer satisfaction score Funds required versus raised for GDF missions 100% Funds required versus raised for GDF grants 80% Funds required versus raised for administrative/operating costs 100% Ratio of orders which are in line with country regimens 100% Number of deviations in routine maintenance of Order Management System 0%
33 ANNUAL REPORT 2011 Annex 2 Patient Treatments by Regions / Countries Country 2011 FLD adult curative FLD adult prophylaxis FLD paediatric curative FLD paediatric prophylaxis All FLD curative All FLD prophylaxis All FLD curative & prophylaxis SLD Afghanistan 10 708 19 485 37 287 30 193 37 287 67 480 27 Armenia 3 653 3 653 3 653 99 Azerbaijan 1 550 1 550 1 550 940 Bangladesh 276 335 276 335 276 335 150 Belarus 93 Belize Bhutan Bolivia 17 Bosnia and Herzegovina Benin 2 575 2 575 2 575 Bhutan 2 396 266 123 2 663 123 2 786 Botswana 153 Bulgaria 68 Burkina Faso 296 3 595 296 3 595 3 890 63 Burundi 5 107 5 107 5 107 Cambodia 9 857 4 786 14 643 14 643 78 China 1 154 Cameroon 1 283 1 268 1 283 1 268 2 551 Colombia 151 Cape Verde 411 464 24 76 435 540 975 Central African Republic 14 354 14 354 14 354 Congo 13 075 13 075 13 075 Costa Rica Côte d'Ivoire 39 785 1 632 16 254 41 417 16 254 57 671 Democratic People's Republic of Korea Democratic Republic of the Congo Democratic Republic of Timor-Leste 134 890 134 890 134 890 42 945 42 945 42 945 138 Dominican Republic 41 Djibouti 3 786 7800 732 162 4 517 7 962 12 480 Ecuador 119 Egypt 12 El Salvador 6 7 11
Page 1 and 2: GLOBAL DRUG FACILITY ANNUAL REPORT
Page 3 and 4: Contents 02 | About the Global Drug
Page 5 and 6: 03 ANNUAL REPORT 2011 Message from
Page 7 and 8: 05 ANNUAL REPORT 2011 GDF was estab
Page 9 and 10: 07 ANNUAL REPORT 2011 Commodity exp
Page 11 and 12: 9 ANNUAL REPORT 2011 2010 GDF Grant
Page 13 and 14: 11 ANNUAL REPORT 2011 Historical an
Page 15 and 16: 13 ANNUAL REPORT 2011 80 70 60 Proc
Page 17 and 18: 15 ANNUAL REPORT 2011 2010 2011 Fre
Page 19 and 20: 17 ANNUAL REPORT 2011 There were ot
Page 21 and 22: 19 ANNUAL REPORT 2011 Diagnostics I
Page 23 and 24: 21 ANNUAL REPORT 2011 First-line dr
Page 25 and 26: 23 ANNUAL REPORT 2011 MDR-TB throug
Page 27 and 28: 25 ANNUAL REPORT 2011 Stockpile In
Page 29 and 30: 27 ANNUAL REPORT 2011 Key performan
Page 31 and 32: 29 ANNUAL REPORT 2011 Review • An
Page 33: 31 ANNUAL REPORT 2011 Monitoring mi
Page 37 and 38: 35 ANNUAL REPORT 2011 Country 2011
Page 39 and 40: 37 ANNUAL REPORT 2011 Country Suppl
Page 41 and 42: 39 ANNUAL REPORT 2011 WHO Region Co
Page 43 and 44: 41 ANNUAL REPORT 2011 Annex 5 GeneX
Page 45 and 46: 43 ANNUAL REPORT 2011 Countries rev
Page 48: Stop TB Partnership www.stoptb.org

Global Drug Facility Annual Report 2011 [.pdf] - Stop TB Partnership

Create successful ePaper yourself

Delete template?

Save as template?